Exact Sciences rose Friday after the Food and Drug Administration approved its next-generation colon cancer detection test, ...

That’s why timely screening should be part of your regular health check-upPurdue University’s Center for Healthy Living (CHL), in conjunction with Cologuard® and Exact Sciences, is providing no-cost, ...

Exact Sciences shares plunged Wednesday after the company reported widening losses. The maker of the Cologuard colon cancer ...

The firm's analysis indicates that the launch of Cologuard Plus in late Q1 2025 or early Q2 2025 could significantly impact revenue, with a projected reimbursement rate of $592 for Medicare Fee ...